Making the Connection Between Patients and Providers
An Interactive Online CME Conference Experience | SEPTEMBER 12, 2020
Engaging Panel Discussions
6 CME Credits
Live Q&A Sessions with Experts
Networking with Professionals
A ONE-OF-A-KIND VIRTUAL CME Conference Experience
For Healthcare Professionals… FROM AROUND THE WORLD!
We’re excited to bring cutting-edge education to you from the comfort of home, wherever you are in the world! We’ve got a dynamic lineup of expert speakers presenting breakthrough diabetes research on the latest advances in treating type 1 and type 2 diabetes through interactive lectures—all with the goal of advancing your practice and opening two-way communication with your patients to activate their involvement in their diabetes management and improve long-term outcomes.
SATURDAY, SEPTEMBER 12, 2020
8:00am – 3:00pm PDT: Conference Program
This event will be hosted on Zoom. All registered participants will receive a link via email to join the event. If you have not used Zoom before you can test out the functionality before the event using Zoom Test Room.
This event is $25.
Don’t forget to tell your patients with diabetes about the VIRTUAL TCOYD Conference and Health Fair— a life-changing day of education, motivation and empowerment to give people living with diabetes the tools they need to take a more active role in their health. LEARN MORE HERE.
Looking for detailed
and speaker information?
Presenter Slide Decks
Download the presentation slide decks ahead of time
and save them to your laptop or tablet!
NOTE: Adding event to your calendar does not register you for the event. To register, please click “REGISTER NOW” button.
WHY YOU NEED TO “MAKE THE CONNECTION“
This UNIQUE EVENT offers the engagement and entertainment of an in-person CME CONFERENCE while ENHANCING THE USER EXPERIENCE with specialized components including:
INTERACTIVE presentations from EXPERTS in diabetes treatment
ENGAGING PANEL DISCUSSIONS on modern topics as they develop daily
Earn 6 CME CREDITS*
Extended LIVE Q&A on topics YOU want to discuss
Networking with healthcare professionals FROM AROUND THE WORLD
INFORMATIONAL LECTURES available for one week after the conference*
*If you have already participated in a 2020 Making the Connection (either live or virtual) event, you cannot claim credit twice
*Lectures will be online after the conference for pre-registered participants. Please note that attendees must attend the virtual/live conference in order to claim credit, as the recorded lectures are not accredited and attendees cannot claim credit for watching post conference.
We focus on four distinct areas of the most cutting-edge diabetes management strategies:
• Patient-provider relationships with a focus on communication methods to improve adherence and persistence
• Oral agents for the treatment of type 2 diabetes and their effect on cardiovascular health
• Injectable therapies, including insulin, for use in patients with type 2 diabetes and their cardiovascular impact
• Time in range and the unmet needs of type 1 diabetes
EXPERT SPEAKERS & INFORMATIVE PRESENTATIONS – A rare opportunity to get modernized education from the nation’s leading experts in diabetes care and management from the comfort of home.
STATE-OF-THE-ART PRESENTATIONS– Interactive presentations with groundbreaking information presented by powerhouse speakers and opinion leaders in diabetes care.
LIVE Q&A DISCUSSIONS – A unique live discussion where you can get your questions answered in real-time by seasoned healthcare professionals.
NETWORKING ON AN INTERNATIONAL LEVEL – Interact & engage with healthcare providers from all over the world on a group or individual level and make professional connections.
RE-WATCH LECTURES AND DISCUSSIONS FOR 1 WEEK* – All educational lectures and live Q&A sessions will be recorded and available for 1 week after the event. PDF lectures are all presentations are also included to ensure you get the most out of this educational experience.
*Lectures will be online after the conference for pre-registered participants. Please note that attendees must attend the virtual/live conference in order to claim credit, as the recorded lectures are not accredited, and attendees cannot claim credit for watching post conference.
“This virtual conference was just FABULOUS! The reach far surpassed any reach you’ve had before. I continue to see ways that the current situation has changed some paradigms FOR THE BETTER. Today was a BEAUTIFUL illustration of that.”
– 2020 Virtual Conference Participant
|8:00AM - 8:15AM||Program Overview & Introduction
Steven V. Edelman, MD
|8:15AM - 9:15AM||Understanding and Addressing Problematic Adherence to Oral and Injectable Cardiometabolic Medications
William Polonsky, PhD, CDE
|9:15AM - 10:30AM||A Focus on Time in Range, Unmet Needs and Modern Management of Type 1 Diabetes
Jeremy H. Pettus, MD
|10:30AM - 11:00AM||Break|
|11:00AM - 12:30PM||Effective Use of Oral Medications for Type 2 Diabetes: Lowering Cardiovascular Risk While Improving Glycemic Control
Juan P. Frias, MD
|12:30PM - 1:00PM||Break|
|1:00PM - 2:15PM||Practical Application of Injectable Agents and Their Cardiovascular Effects: Individualized Treatment Strategies
Steven V. Edelman, MD
|2:15PM - 2:45PM||Combined Patient-Provider Workshop:
Doctors Are From Mars, Patients Are From Venus
William Polonsky, PhD, CDE, and Steven V. Edelman, MD
|2:45PM - 3:00PM||Closing Session|
*Steven V. Edelman, MD
TCOYD Founder & Director
Dr. Edelman is the founder and director of Taking Control Of Your Diabetes (TCOYD), a professor of medicine in the Division of Endocrinology, Diabetes & Metabolism at the University of California, San Diego (UCSD) and the Veterans Affairs (VA) Healthcare System of San Diego. He is also the director of the Diabetes Care Clinic at the VA Medical Center. Dr. Edelman, who has type 1 diabetes himself, has written more than 200 articles, five books, and has won numerous awards for teaching and humanitarianism. He has been chosen by the medical students at UCSD as the ‘teacher of the year’ numerous times. Among his many honors, Dr. Edelman has received the ‘Diabetes Educator Of The Year’ award by the American Diabetes Association, the ‘Distinction in Endocrinology’ award by the American Association of Clinical Endocrinologists, and named ‘Top 1% of U.S. Endocrinologists’ by US News and World Report
William Polonsky, PhD, CDE
Clinical Psychologist; Founder & CEO, Behavioral Diabetes Institute
Dr. Polonsky is President and Founder of the Behavioral Diabetes Institute, the world’s first organization totally dedicated to studying and addressing the unmet psychological needs of people with diabetes. He is also Associate Clinical Professor in Psychiatry at the University of California, San Diego. Dr. Polonsky received his PhD in clinical psychology from Yale University and has served as Senior Psychologist at the Joslin Diabetes Center in Boston, faculty member at Harvard Medical School and Chairman of the National Certification Board for Diabetes Educators. A licensed clinical psychologist and certified diabetes educator, he received the American Diabetes Association’s 2014 Richard R. Rubin Award for distinguished contributions to behavioral medicine and psychology. Dr. Polonsky’s most recent research projects have focused on quality of life in diabetes, diabetes-related distress and depression, hypoglycemic fear, and glucose monitoring behavior and attitudes in people living with diabetes.
*Jeremy Pettus, MD
Type 1 Track and Professional Education Director, Endocrinologist, Associate Professor of Medicine, UCSD School of Medicine
Dr. Jeremy Pettus was diagnosed with type 1 diabetes when he was 15 years old. Since that time he has dedicated his career to educating and treating others like himself. He is currently an Endocrinologist and Assistant Professor of Medicine at the University of California, San Diego. There, he focuses primarily on clinical trials to develop and test new and innovative therapies for people living with diabetes. These include studies ranging from medications to reverse or slow the disease once it occurs, to islet cell transplantation strategies, to device studies such as artificial pancreas technology. As somebody who has the disease himself, sees patients with type 1, and is actively working on curing/treating the disease, we are honored to have him as our Type 1 Track director. Dr. Pettus travels across the country and the world meeting other leading physicians and scientists and brings this information directly to TCOYD conference participants.
Juan Pablo Frias, MD
CEO, Principal Investigator, National Research Institute
Dr. Frias, a native of Chile, is currently President and Principal Investigator of National Research Institute in Los Angeles, CA. He completed his undergraduate studies at the University of Florida and received his medical degree from Vanderbilt University School of Medicine. After serving 5 years as a General Medical Officer in the US Navy, he completed his training in Internal Medicine at Vanderbilt University and the University of Tennessee, and his Fellowship in Endocrinology, Diabetes and Metabolism at the University of California, San Diego. Dr. Frias has held leadership positions in Clinical and Medical Affairs at Eli Lilly, Amylin Pharmaceuticals, Pfizer, and Johnson and Johnson, where he served as Chief Medical Officer and Global Vice President of Clinical and Medical Affairs, Diabetes Care. He has held academic positions at the University of Colorado Health Sciences Center, Barbara Davis Center for Diabetes, and the University of California San Diego School of Medicine, where he is currently on the clinical faculty. Dr. Frias has been involved in diabetes and metabolism-related research for over 20 years and has authored numerous publications in this field.
At course completion, participants should be able to:
|1. Identify the different pathophysiologic defects associated with type 2 diabetes and how all the pharmacologic agents (oral and injectable) address these specific abnormalities.||7. Design a treatment plan for multiple daily injection regimens and insulin pump therapy.|
|2. Develop individualized treatment strategies based on the living standards of care and patient characteristics.||8. Explain how to interpret continuous glucose monitoring (CGM) data.|
|3. Discuss the recently published cardiovascular-renal outcome trials on oral and injectable type 2 medications.||9. Demonstrate the ability to select effective therapeutic adjustments based on CGM trending or rate of change arrows, time in range, and standard deviation.|
|4. Summarize the most up-to-date clinical information on GLP-1 RA and SGLT-2 inhibitors.||10. Recognize the physical and emotional barriers that prevent patients with diabetes from being persistent and adherent to their therapeutic regimen(s).|
|5. Evaluate the use of SGLT-2 and GLP-1 RA in patients who have cardiovascular risks factors and are at risk or have a history of atherosclerotic cardiovascular disease (ASCVD).||11. Employ innovative and dynamic strategies for communication with patients to strengthen provider-patient relations and improve patient outcomes.|
|6. Discuss approaches to combination therapy with the currently available oral agents, as well as physician and patient-directed insulin titration strategies and the basal-bolus approach.|
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of California, San Diego School of Medicine and Taking Control of Your Diabetes. The University of California, San Diego School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
AMA: The University of California, San Diego School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: For the purposes of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of re-licensure, the California Board of Registered Nursing accepts AMA PRA Category 1 credits™ (report up to 6.0 hours of credit and list “CME Category 1” as the provider number).
Physician Assistants: The AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 6.0 hours of Category 1 credit for completing this program.
Certified Diabetes Educators: The University of California, San Diego is accredited by the ACCME, which is on the NCBDE list of approved providers.
Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Global Education Group designates this continuing education activity for 6.0 contact hour(s) (0.6 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number – 0530-9999-20-092-L01-P)
This is a knowledge based activity.
Attention HCPs from outside of the US: To see if you are eligible to receive CME credits check here.
GET YOUR CME CREDITS HERE!
Attend the Conference. Get the Code. Get Your Credits!
After you have attended the Making the Connection conference click below to claim your CME credit. Be sure to reference your credit access code, found in the materials you will receive on the day of the conference.